hydroxyproline has been researched along with Endometrioma in 7 studies
Hydroxyproline: A hydroxylated form of the imino acid proline. A deficiency in ASCORBIC ACID can result in impaired hydroxyproline formation.
hydroxyproline : A proline derivative that is proline substituted by at least one hydroxy group.
Endometrioma: An enlarged area of ENDOMETRIOSIS that resembles a tumor. It is usually found in the OVARY. When it is filled with old blood, it is known as a chocolate cyst.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Medical 'oophorectomy' by GnRH agonist or danazol is an effective treatment for endometriosis." | 9.06 | Evidence of similar increases in bone turnover during nafarelin and danazol use in women with endometriosis. ( Hirvonen, E; Nilsson, CG; Viinikka, L; Ylikorkala, O, 1990) |
| "The effects of danazol and buserelin on the bone mineral content (BMC) of 19 Japanese women with endometriosis were studied." | 5.08 | Changes in bone mineral content following hormone treatment for endometriosis. ( Fukushima, M, 1995) |
| "Medical 'oophorectomy' by GnRH agonist or danazol is an effective treatment for endometriosis." | 5.06 | Evidence of similar increases in bone turnover during nafarelin and danazol use in women with endometriosis. ( Hirvonen, E; Nilsson, CG; Viinikka, L; Ylikorkala, O, 1990) |
| "Our purpose was to investigate the effects of nafarelin on bone turnover and mass (bone mineral density, in grams per square centimeter) in women with endometriosis." | 3.69 | Effects of a gonadotropin-releasing hormone agonist on the calcium-parathyroid axis and bone turnover in women with endometriosis. ( Heinrichs, L; Henzl, M; Holloway, L; Marcus, R; Monroe, SE; Newhall-Perry, K; Osburn, L, 1995) |
| " In young women estrogen-deficiency bone loss is a clinical problem associated with the use of luteinizing hormone releasing hormone (LHRH) agonists, such as buserelin, to treat endometriosis." | 3.68 | Preventive effects of clomiphene citrate on estrogen-deficiency osteopenia elicited by LHRH agonist administration in the rat. ( Fisher, L; Goulding, A, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 6 (85.71) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Newhall-Perry, K | 1 |
| Holloway, L | 1 |
| Osburn, L | 1 |
| Monroe, SE | 1 |
| Heinrichs, L | 1 |
| Henzl, M | 1 |
| Marcus, R | 1 |
| Fukushima, M | 1 |
| Borderie, D | 1 |
| Cherruau, B | 1 |
| Dougados, M | 1 |
| Ekindjian, OG | 1 |
| Roux, C | 1 |
| Amama, EA | 1 |
| Taga, M | 1 |
| Minaguchi, H | 1 |
| Goulding, A | 1 |
| Fisher, L | 1 |
| Ylikorkala, O | 1 |
| Nilsson, CG | 1 |
| Hirvonen, E | 1 |
| Viinikka, L | 1 |
| Shoda, H | 1 |
3 trials available for hydroxyproline and Endometrioma
| Article | Year |
|---|---|
Changes in bone mineral content following hormone treatment for endometriosis.
Topics: Adult; Alkaline Phosphatase; Bone Density; Buserelin; Creatinine; Danazol; Endometriosis; Estradiol; | 1995 |
Biochemical markers as predictors of bone mineral density changes after GnRH agonist treatment.
Topics: Adult; Alkaline Phosphatase; Amenorrhea; Amino Acids; Biomarkers; Bone Density; Calcium; Cohort Stud | 1998 |
Evidence of similar increases in bone turnover during nafarelin and danazol use in women with endometriosis.
Topics: Alkaline Phosphatase; Analysis of Variance; Bone Density; Bone Regeneration; Calcitonin; Calcium; Da | 1990 |
4 other studies available for hydroxyproline and Endometrioma
| Article | Year |
|---|---|
Effects of a gonadotropin-releasing hormone agonist on the calcium-parathyroid axis and bone turnover in women with endometriosis.
Topics: Adult; Bone and Bones; Bone Density; Bone Remodeling; Calcitriol; Calcium; Endometriosis; Female; Go | 1995 |
The effect of gonadotropin-releasing hormone agonist on type I collagen C-telopeptide and N-telopeptide: the predictive value of biochemical markers of bone turnover.
Topics: Adult; Alkaline Phosphatase; Amino Acids; Antineoplastic Agents, Hormonal; Biomarkers; Bone Remodeli | 1998 |
Preventive effects of clomiphene citrate on estrogen-deficiency osteopenia elicited by LHRH agonist administration in the rat.
Topics: Animals; Bone Diseases, Metabolic; Bone Resorption; Buserelin; Calcium; Clomiphene; Endometriosis; E | 1991 |
[A comparative study of the peri-focal stromal reaction in endometrial carcinoma and internal endometriosis].
Topics: Endometriosis; Female; Glycosaminoglycans; Humans; Hydroxyproline; Microbial Collagenase; Uterine Ne | 1986 |